About
Andreas Jurgeit joined Gimv's Health & Care team in 2021. He previously worked at Lundbeckfonden Emerge in Copenhagen and at Merck Ventures in Amsterdam, where he handled VC investments and company creation across Europe, the US, and Israel, and began his career at Redalpine Venture Partners in Zurich. He holds a PhD in Cell Biology/Virology from the University of Zurich and a master's degree in Molecular Biology from the University of Innsbruck.
Invests in
BiotechDigital HealthHealthtech
Experience
- GimvPartnercurrent2021 — present
- EXCIVA GmbHBoard Membercurrent2025 — present
- Mediar TherapeuticsBoard Membercurrent2022 — presentBoston, Massachusetts, United States
- ImmunOs Therapeutics AGBoard Membercurrent2022 — presentGreater Zurich Area
- Innosuisse - Schweizerische Agentur für InnovationsförderungCoach and Lecturercurrent2018 — presentZürich Area, Switzerland
- ETH Zurich / IFJ start-up essentialsLecturer2015 — 2023Zürich Area, Switzerland
- LundbeckfondenPartner, Lundbeckfonden Emerge2018 — 2021
- DNA ScriptBoard Member2017 — 2018
- Indi Molecular, Inc.Board Member2017 — 2018
- Merck VenturesDirector2016 — 2018
- Paul Scherrer Institut (PSI)Startup Creation2015 — 2016
- Redbiotec AGBusiness Development and Strategy2013 — 2015Zürich Area, Switzerland
- Redalpine Venture Partners AGInvestment Advisor2013 — 2014Zürich Area, Switzerland
- Redalpine Venture Partners AGInvestment Manager at Redalpine Venture Partners2012 — 2014Zürich Area, Switzerland
- Redalpine Venture Partners AGAssociate2011 — 2012Zürich Area, Switzerland
- University of ZurichPhD/PostDoc (Target Discovery, Antivirals)2006 — 2011
- Medizinische Universitaet InnsbruckResearch Assistant2005 — 2006
- Universität InnsbruckMasters in Molecular Biology / Biochemistry2001 — 2005Innsbruck
Education
- University of ZürichPhD, Molecular Cell Biology & Virology2006 — 2010
- University of InnsbruckMaster of Science (MSc), Molecular Biology / Biochemistry2001 — 2005
- BRG Woergl
Skills & more
Venture Capital23Life Sciences16Drug Discovery5Research2Marketing Communications1Business Strategy10Market ResearchVirology9Cancer ResearchBiomarkersCell Biology10Image Analysis
+12 more
Cell Based AssaysBiopharmaceuticalsBiochemistryInfectious DiseasesLifesciencesImmunologyCellCell CultureStrategic PlanningStrategyManagementMolecular BiologyFrom Andreas's professional profile.
Shared employers
Also worked at EXCIVA GmbH4
Also worked at ImmunOs Therapeutics AG3
Also worked at Innosuisse - Schweizerische Agentur für Innovationsförderung10
Martin ScherrerPartner & Head of Managed Funds at RedstoneAnja KoenigGlobal Head of NVF at Novartis Venture FundReinhard VoelkelInvestor at Sand Hill AngelsMichael SidlerFounding Partner at redalpineMatt LashmarManaging Director, MassChallenge Switzerland at MassChallenge MexicoCara TobinInvestor at Clean Energy Venture
%20(4).avif)
+ 4 more
Also worked at DNA Script10
Chris BarbazetteExecutives in Residence at GENERAL INCEPTIONGuillaume BaxterPartner at Sofinnova PartnersKeno GutierrezGeneral Partner at BioGeneration VenturesPhilippe PeltierPartner at Kurma PartnersNick NaclerioFounding Partner at Illumina VenturesWouter MeulemanPartner at Illumina Ventures
+ 4 more
